Phenylalanine acts as an allosteric activator of the tetrahydropterin-dependent enzyme phenylalanine hydroxylase. Hydrogen/deuterium exchange monitored by mass spectrometry has been used to gain insight into local conformational changes accompanying activation of rat phenylalanine hydroxylase by phenylalanine. Peptides in the regulatory and catalytic domains that lie in the interface between these two domains show large increases in the extent of deuterium incorporation from solvent in the presence of phenylalanine. In contrast, the effects of phenylalanine on the exchange kinetics of a mutant enzyme lacking the regulatory domain are limited to peptides surrounding the binding site for the amino acid substrate. These results support a model in which the N-terminus of the protein acts as an inhibitory peptide, with phenylalanine binding causing a conformational change in the regulatory domain that alters the interaction between the catalytic and regulatory domains.Phenylalanine hydroxylase (PheH) 1 is a mononuclear non-heme iron containing monooxygenase that catalyzes the hydroxylation of phenylalanine to tyrosine using molecular oxygen and tetrahydrobiopterin (BH 4 ) (1). This is the rate-limiting step in the catabolism of dietary phenylalanine in the liver. A deficiency in PheH causes the genetic disease phenylketonuria, a common metabolic disorder resulting in mental retardation (2). PheH belongs to the aromatic amino acid hydroxylase family, along with tyrosine hydroxylase (TyrH) and tryptophan hydroxylase (3). The latter two enzymes hydroxylate tyrosine and tryptophan in the biosynthetic pathways for the catecholamine neurotransmitters and serotonin, respectively. The three enzymes have similar chemical † This work was supported in part by grants from the NIH (R01 GM47291) and The Welch Foundation (AQ-1245).*Address correspondence to: Paul F. Fitzpatrick, Department of Biochemistry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900, ph: 210-567-8264; fax: 210-567-8778, fitzpatrick@biochem.uthscsa.edu. 1 Abbreviations used: PheH, phenylalanine hydroxylase; Δ117PheH, rat PheH lacking the N-terminal 117 residues; TyrH, tyrosine hydroxylase; BH 4 , tetrahydrobiopterin; HXMS, hydrogen/deuterium exchange mass spectrometry; NTA, nitriloacetic acid; MS/MS, tandem mass spectrometry.
NIH Public Access Author ManuscriptBiochemistry. Author manuscript; available in PMC 2011 April 20.
Published in final edited form as:Biochemistry. The structural basis for activation of PheH by phenylalanine is not known. The only available structures of PheH with an amino acid substrate bound are ternary complexes consisting of the catalytic domain of human PheH with BH 4 and 3-(2-thienyl)-L-alanine or L-norleucine (17,18). These structures provide no insight into the changes in the regulatory domain associated with phenylalanine or BH 4 binding. Indeed, the isolated catalytic domain does not require activation by phenylalanine (19). The only crystal structure containing th...